Patents Assigned to Immport Theerapeutics, Inc.
  • Compositions and methods for immunodominant antigens of
    Patent number: 9494586
    Abstract: Contemplated compositions, devices, and methods are drawn to various antigens from the pathogen M. tuberculosis and their use in vaccines, therapeutic agents, and various diagnostic tests. In particularly preferred aspects, the antigens are immunodominant and have quantified and known relative reactivities with respect to sera of a population infected with the pathogen, and/or have a known association with a disease parameter.
    Type: Grant
    Filed: October 12, 2014
    Date of Patent: November 15, 2016
    Assignee: Immport Theerapeutics, Inc.
    Inventors: Philip Felgner, Xiaowu Liang, Maria Laura Gennaro